Nanomedicine activation profile determines efficacy
depending on tumor c-Myc expression

The Innovation Center of NanoMedicine reported in ACS
Nano together with the group of Prof. Yu Matsumoto of
Otorhinolaryngology and Head and Neck Surgery and the group of
Prof. Horacio Cabral of the Department of Bioengineering in the
University of Tokyo that the efficacy of polymeric nano-micelles
with different drug activation profile depends on the expression
level of c-Myc, one of the major proto-oncogenes, has been
developed.